首页> 外文期刊>Annals of Internal Medicine >Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: A randomized trial
【24h】

Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: A randomized trial

机译:药师干预对出院后临床上重要的用药错误的影响:一项随机试验

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Clinically important medication errors are common after hospital discharge. They include preventable or ameliorable adverse drug events (ADEs), as well as medication discrepancies or nonadherence with high potential for future harm (potential ADEs). Objective: To determine the effect of a tailored intervention on the occurrence of clinically important medication errors after hospital discharge. Design: Randomized, controlled trial with concealed allocation and blinded outcome assessors. (ClinicalTrials.gov registration number: NCT00632021) Setting: Two tertiary care academic hospitals. Patients: Adults hospitalized with acute coronary syndromes or acute decompensated heart failure. Intervention: Pharmacist-assisted medication reconciliation, inpatient pharmacist counseling, low-literacy adherence aids, and individualized telephone follow-up after discharge. Measurements: The primary outcome was the number of clinically important medication errors per patient during the first 30 days after hospital discharge. Secondary outcomes included preventable or ameliorable ADEs, as well as potential ADEs. Results: Among 851 participants, 432 (50.8%) had 1 or more clinically important medication errors; 22.9% of such errors were judged to be serious and 1.8% life-threatening. Adverse drug events occurred in 258 patients (30.3%) and potential ADEs in 253 patients (29.7%). The intervention did not significantly alter the per-patient number of clinically important medication errors (unadjusted incidence rate ratio, 0.92 [95% CI, 0.77 to 1.10]) or ADEs (unadjusted incidence rate ratio, 1.09 [CI, 0.86 to 1.39]). Patients in the intervention group tended to have fewer potential ADEs (unadjusted incidence rate ratio, 0.80 [CI, 0.61 to 1.04]). Limitation: The characteristics of the study hospitals and participants may limit generalizability. Conclusion: Clinically important medication errors were present among one half of patients after hospital discharge and were not significantly reduced by a health-literacy-sensitive, pharmacistdelivered intervention. Primary Funding Source: National Heart, Lung, and Blood Institute.
机译:背景:出院后常见临床上重要的用药错误。它们包括可预防或可改善的不良药物事件(ADE),以及药物差异或不依从性,极有可能造成未来伤害(潜在ADEs)。目的:确定量身定制的干预措施对出院后临床上重要的药物错误发生的影响。设计:随机对照试验,采用隐蔽分配和盲目的结果评估者。 (ClinicalTrials.gov注册号:NCT00632021)设置:两家三级护理学术医院。患者:患有急性冠状动脉综合征或急性代偿性心力衰竭的成年人。干预措施:药剂师协助的药物和解,住院药剂师辅导,低素养依从性辅助工具以及出院后的个性化电话随访。测量:主要结局是出院后前30天内每位患者的临床重要用药错误数。次要结果包括可预防或可改善的ADE,以及潜在的ADE。结果:851名参与者中,432名(50.8%)有1个或更多具有重要临床意义的用药错误;此类错误中有22.9%被认为是严重错误,有1.8%威胁生命。药物不良反应发生在258例患者中(30.3%),潜在的ADEs在253例患者中(29.7%)。干预措施并未显着改变每位患者的临床重要用药错误(未调整的发生率,0.92 [95%CI,0.77至1.10])或ADEs(未调整的发生率,1.09 [CI,0.86至1.39])。 。干预组的患者倾向于具有较少的潜在ADE(未调整的发生率,0.80 [CI,0.61至1.04])。局限性:研究医院和参与者的特征可能会限制普遍性。结论:临床上重要的用药错误存在于出院后的一半患者中,并且通过对健康素养敏感的药剂师提供的干预措施并不能显着减少。主要资金来源:国家心脏,肺和血液研究所。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号